Kari M. Morrissey
35 works · 2,658 citations · h-index 21
Top works
- Renal Transporters in Drug Development
- OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin
- The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
- The UCSF-FDA TransPortal: A Public Drug Transporter Database
- Modeling, Prediction, and in Vitro in Vivo Correlation of CYP3A4 Induction
- Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
- Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational Modeling
- Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
- A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to Metformin
- Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
- Consequences of POR mutations and polymorphisms
- Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro
- First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma
- Abstract CT302: Phase Ia/Ib dose-escalation study of the anti-TIGIT antibody tiragolumab as a single agent and in combination with atezolizumab in patients with advanced solid tumors
- Expanding the Role of the Dynein Regulatory Complex to Non‐Axonemal Functions: Association of GAS11 with the Golgi Apparatus
- A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer
- Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors
- The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers
- A phase Ib dose escalation study of combined inhibition of IDO1 (GDC-0919) and PD-L1 (atezolizumab) in patients (pts) with locally advanced or metastatic solid tumors.
- Genome-Wide Discovery of Drug-Dependent Human Liver Regulatory Elements